Recent Finacing
Recent Raise
Innerva Pharmaceuticals develops an ophthalmic formulation that blocks PIEZO2 in mechanosensitive nociceptors to reduce ocular pain from dry eye, post‑surgical and chronic surface ocular diseases, advancing toward human trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor